Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatography-based one-step in vitro test designed for the simultaneous qualitative detection of SARS-CoV-2, Influenza A, and Influenza B antigens. It enables multiplex respiratory pathogen screening in a single test format.
Manufactured by
Xiamen, Fujian, China
Specializes in developing and manufacturing in vitro diagnostic kits, including point of care and immunoassay products for global markets. Operates a 12,500 square meter facility under ISO 13485:2016 and GMP guidelines, with products approved by China NMPA and exported to over 70 countries. Focuses on diagnostic rapid tests and offers customized solutions alongside comprehensive technical support services.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Oxalis Diagnostics Pvt Ltd
India · 1 relevant product
Hangzhou AllTest Biotech Co.,Ltd
China · 8 relevant products
SureScreen Diagnostics Limited
United Kingdom · 5 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 4 relevant products
Operon S.A.
Spain · 3 relevant products
Qingdao Hightop Biotech Co., Ltd
China · 1 relevant product
Hangzhou Realy Tech Co., Ltd
China · 2 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
Biopanda Reagents
United Kingdom · 4 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Oxalis Diagnostics Pvt Ltd · India
A rapid diagnostic test card for simultaneous detection of Dengue IgG, IgM antibodies and NS1 antigen using chromatographic immunoassay. Available in pack size of 10 tests. This combination test provides comprehensive Dengue virus detection.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of SARS-CoV-2, Influenza A+B, and respiratory syncytial virus. This test provides comprehensive assessment for major respiratory viral infections.
SureScreen Diagnostics Limited · United Kingdom
A multiplex rapid antigen test simultaneously detecting SARS-CoV-2 and Influenza A/B viruses. Enables differential diagnosis of co-circulating respiratory pathogens in a single test. Results available within minutes for rapid clinical assessment and patient triage.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that simultaneously detects SARS-CoV-2 and Influenza A+B antigens using a swab sample for point-of-care diagnosis.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A and B from nasal swab samples. This multiplex test enables quick differentiation between respiratory viral infections in clinical and point-of-care settings.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
SureScreen Diagnostics Limited · United Kingdom
A combined rapid test cassette for simultaneous detection of SARS-CoV-2 and influenza A/B antigens in a single test.
Operon S.A. · Spain
A rapid diagnostic test for the simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 in human samples. Used for in vitro diagnosis of respiratory infections.
Qingdao Hightop Biotech Co., Ltd · China
Rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A+B from respiratory specimens. Delivers results within 15-20 minutes, enabling quick triage and differential diagnosis in clinical and point-of-care settings. Colloidal gold immunochromatographic technology provides high sensitivity and specificity for acute respiratory infection management.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that simultaneously detects SARS-CoV-2 and Influenza A+B antigens using a nasopharyngeal swab for point-of-care diagnosis.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid diagnostic test that detects antigens for SARS-CoV-2, Influenza A+B, RSV, and Adenovirus in a single test.
Hangzhou Realy Tech Co., Ltd · China
A multiplex rapid test cassette for simultaneous detection of SARS-Cov-2, Influenza A, and Influenza B antigens using swab samples. This combination test allows concurrent screening for multiple respiratory pathogens.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products